$OCUL can rise in the next days

Contextual immersion trading strategy idea.

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology.

The share price rose after the company announced topline phase 1 clinical trial results of OTX-CSI.

The demand for shares of the company still looks higher than the supply.

These and other conditions can cause a rise in the share price in the next days.

So I opened a long position from $11,22;
stop-loss — $10,00.

Information about take-profits will be later.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.

Thanks for being with me!

Trade active:

stop set at $10,07

Trade active:

stop set at $10,67

Trade closed: stop reached